transcripts, has been implicated in long-term suppression of HIV replication in elite controllers (2) .
Another group of host proteins can inhibit the movement of mobile genetic elements, such as endogenous retroviruses and retrotransposons, in the germ line (8) (9) (10) . They are called P-element-induced wimpy like (Piwil) proteins (11) . As members of the argonaute family of proteins, they bind to small Piwi-interacting RNAs (piRNAs), which are slightly larger than miRNAs (12) . piRNAs contain sequences that are complementary to and thus restrict the movement of mobile genetic elements in the germ line (8) . In their absence, spermatogenesis is inhibited and male mice are sterile. In humans, there are 4 Piwil proteins, and they are called Hiwi, Hili, Piwil 3, and Hiwi 2 (10, 13) . Some of them are also expressed in many tumors, especially those of the reproductive system, e.g., seminomas (14, 15) . They are thought to increase malignant transformation by inhibiting p53, which is a tumor suppressor (16) . Of interest, in somatic cells, rather than binding to piRNAs, which contain retroviral or retrotransposon sequences, Piwil proteins bind to tRNAs (17) (18) (19) .
In this report, we discovered that Piwil proteins also inhibit the replication of HIV. For example, Hili and Mili (the mouse Piwil 2 protein) decreased levels of viral proteins in cells. They also inhibited the expression of the native green fluorescent protein (GFP) but not of its codon-optimized counterpart (enhanced green fluorescent protein [EGFP] ). We also noted increased expression of Hili upon T cell activation. In all of these scenarios, genetic inactivation of Hili increased levels of HIV replication. Since the amounts of viral transcripts did not change, we suspected that Hili inhibited their translation. Indeed, Hili bound to tRNAs. Of these, Hili favored rare tRNA Arg (UCU) and tRNA Ile (UAU), whose codons are found abundantly in GFP and HIV transcripts. Importantly, removing the rare tRNA Arg (UCU) via antisense (AS) oligonucleotides recapitulated the effects of the presence of Hili. These findings were duplicated with an endogenous retrovirus, the intracysternal A particle (IAP). Thus, Hili, like Schlafen 11, inhibits HIV replication by interfering with the translation of viral transcripts. Since many of these suboptimal codons are found in areas of RNA secondary structure, HIV cannot easily escape this inhibition.
RESULTS
Piwil proteins inhibit HIV replication. Piwil proteins are related to each other within species and between species (10, 20) . For example, mouse and human Piwil 2 proteins (Mili and Hili) are 88% identical in sequence ( Fig. 1A) . Because Piwil proteins are known to inhibit the movement of mobile genetic elements, we investigated if they could also affect HIV (HIV-1 NL4-3 or pNL4-3) ( Fig. 1A ). To this end, we coexpressed Hili and HIV in 293T cells ( Fig. 1B, bars 1 and 2) . At the same time, we expressed HIV by transfecting pNL4-3 in 293T cells, which stably contained Mili (293T.mili; Fig. 1B, bar 3 ). Supernatants were harvested 2 days after the transfection. Levels of new viral particles were determined by Gag p24 enzyme-linked immunosorbent assay (ELISA). Of note, in the presence of Hili or Mili, 5-or 10-fold-reduced levels of new viral particles were observed from these cells, respectively. Levels of Hili and Mili were determined with appropriate antibodies (Abs) by Western blotting, where tubulin served as the loading control ( Fig. 1B , lower panels, lanes 1 to 3).
To determine if these Piwil proteins affected the infectivity of new viral particles, we used equivalent amounts of viruses from these cells and infected fresh TZM-bl indicator cells. TZM-bl cells express necessary HIV receptors and contain the HIV long terminal repeat (LTR) linked to luciferase and LacZ reporter genes. As presented in Fig. 1C , new viral particles from 293T cells transfected with an empty vector (negative control) (C) and those expressing Hili or Mili were equally infectious (Fig. 1C , bars 1 to 3). Thus, these Piwil proteins did not affect the infectivity of new viral particles.
Next, we wanted to know if Hili affected levels of viral transcripts or proteins. To this end, we coexpressed Hili and the pNL4-3.Luc provirus, which contains the luciferase reporter gene in place of the nef gene, in these cells. We interrogated HIV genomic RNA species using gag-specific primers and reverse transcriptase quantitative PCR (RT-qPCR).
No differences in levels of HIV genomic transcripts were observed between wild-type (WT) cells control (C), and Hili-expressing 293T cells ( Fig. 1D , bars 1 and 2). In contrast, we found 5-fold-lower levels of expression of Gag proteins in Hili-expressing cells (Fig.  1E , lanes 1 and 2). This finding was true for the p55 Gag precursor as well as for its p24 (capsid [CA]) mature product ( Fig. 1E , top panel, lanes 1 and 2). The expression of Hili was monitored by Western blotting, where tubulin again served as the internal control (Fig. 1E , bottom panels, lanes 1 and 2). Finally, despite differences in levels of viral proteins, the levels of luciferase activity of these two cells were equivalent ( Fig. 1F , bars 1 and 2). Importantly, this luciferase reporter gene has been optimized for expression in human cells by substituting rare codons for abundant ones found in humans. From these studies, we conclude that Hili and Mili inhibit HIV replication at the step of translation and that the translation of viral but not codon-optimized transcripts is affected.
Hili inhibits the expression of GFP but not codon-optimized EGFP. Since Schlafen 11 also inhibits primarily the translation of HIV transcripts, we next examined the ability of Hili to affect additional transcripts from other species that were not codon optimized. For example, the green fluorescent protein (GFP) from Aequorea victoria (jellyfish) contains several rare human codons such as Ile-AUA or Arg-AGA ( Fig. 2A ). They were changed in its humanized version (EGFP). To determine if Hili affected the translation of GFP but not EGFP, we coexpressed Hili and these GFP transcripts in 293T cells. Two days later, Western blotting revealed that Hili affected the expression of GFP but not EGFP in these cells ( Fig. 2B and C, top panels, lanes 1 to 4). Densitometric analyses of these bands by the use of a Li-Cor instrument are presented in the top bar graphs ( Fig. 2B and C, bars 1 to 4). Although 5-fold-lower expression of GFP was observed in the presence of Hili, the levels of GFP and EGFP transcripts remained the same ( Fig. 2B and C, lower bar graphs, bars 1 to 4). Expression of Hili was followed by Western blotting, where tubulin again served as the internal control ( Fig. 2B and C, lower two Western blots, lanes 1 to 4). We conclude that Hili affects the expression of only the non-codon-optimized version of GFP.
Cell activation induces the expression of Hili in peripheral blood mononuclear cells (PBMCs) and CD4 ؉ T cells. Thus far, all our studies were carried out in transformed 293T cells, which represent human embryonic kidney cells. Additionally, they express the large T antigen of simian virus 40 (SV40). To determine if Hili plays any role in HIV replication in other transformed indicator and hematopoietic cells as well as in the primary cells that are the natural hosts of HIV, we examined HeLa cells, Jurkat cells, PBMCs, and CD4 ϩ T cells. Of these, HeLa cells are the parental TZM-bl cells, Jurkat cells represent an infectible immature T cell line, and activated PBMCs and CD4 ϩ T cells are the primary target cells in humans. Others previously determined that HeLa and Jurkat cells, unlike 293T cells, express Hili (21) . Thus, we first interrogated if depletion of Hili in these cells increases levels of HIV replication. As presented in Fig. 3A and B, RNA interference (RNAi) applied to Hili with short interfering RNA (siRNA) species increased the production of new viral particles up to 4-fold in HeLa and Jurkat cells. In these cells, Hili was depleted for 24 h before cells were infected with vesicular stomatitis virus (VSV)-G-pseudotyped HIV-1 NL4-3 . At 48 h later, supernatants were harvested and levels of new viral particles were determined by Gag p24 ELISA. In Fig. 3A , the lower bar graph indicates levels of hili mRNA as measured by RT-qPCR and panels below the bar graphs represent Hili and tubulin proteins as determined by Western blotting. A similar presentation is given in Fig. 3B . We also examined PBMCs and CD4 ϩ T cells ( Fig. 3C ). In these cells, levels of hili transcripts were vanishingly low in the resting state, but they increased dramatically following cell activation. For PBMCs, phytohemagglutinin (PHA) and phorbol myristate acetate (PMA) were administered for 2 days (Fig. 3C , left bar graph, bars 1 and 2). For purified CD4 ϩ T cells, activation was performed with anti-CD3 and anti-CD28 antibodies. Two days later, RT-qPCR and Western blotting were performed, with results which indicated increased levels of hili mRNA and protein ( Fig. 3C , bar graph on the right, Western blots below the bar graph, bars 1 and 2). Since levels of Hili were increased in these activated cells, we also used the same siRNA reagents and observed a similar increase in the production of new viral particles in the absence of Hili (Fig. 3D , bar graphs, bars 1 and 2). We conclude that Hili inhibits viral replication in transformed cell lines as well as in activated primary CD4 ϩ T cells, which are the primary target for HIV in humans.
Mili binds to some tRNAs in cells. To determine how Mili could inhibit HIV translation, we next examined RNA species that bind to Mili in cells. 293T cells stably expressing chimeric mili.EGFP (293T.mili) were UV irradiated and lysed. Anti-Piwil 2 and anti-GFP antibodies were then used to immunoprecipitate (IP) Mili and associated RNA species. RNA was released from immunocomplexes, separated by the use of a 15% Tris-borate-EDTA (TBE)-urea gel, and visualized with Sybr gold reagent. Saccharomyces cerevisiae (yeast) tRNA was used as the molecular size marker for tRNA species (Fig. 4A , lane 5). Other RNA size markers were also present (Fig. 4A, lane 1) . Importantly, Mili bound predominantly to RNAs of the same size as the yeast tRNA marker (Fig. 4A , lanes 3, 4, and 5). There was no binding to the IgG control (Fig. 4A, lane 2) . In addition, no smaller RNA species were observed, especially in the 25-to-30-nucleotide range, where one would expect to see piRNAs or degraded tRNA species. Some larger-molecular-size Western blots reveal levels of coexpressed proteins and were normalized to tubulin. Densitometry of Western blots (performed using a Li-Cor instrument) revealed the relative expression levels of GFP in these cells (bar graphs below the Western blots). At the same time, RNA levels of GFP transcripts were determined by RT-qPCR. (C) Hili does not affect the expression of EGFP. The codon-optimized EGFP was coexpressed transiently with an empty vector (C bar) or with Hili (hili bar) in 293T cells. The quantitation of Western blots and EGFP transcripts was performed as described for panel A.
RNA bands were also observed, but they corresponded to those observed with the yeast tRNA or the IgG negative control (Fig. 4A , lanes 3 to 5). We conclude that Mili binds to tRNA in cells.
To investigate further tRNA species that bind to Mili, we performed a modified cross-linked immunoprecipitation-microarray (Clip-chip) analysis (22) . This analysis was preferred to transcriptome sequencing (RNA-seq), which would not reveal correctly relative levels of tRNAs of low abundance, i.e., rare tRNA species. 293T.mili cells were first UV irradiated. RNA bound to Mili was immunoprecipitated with anti-Piwil 2 antibodies, subjected to 3=-end 32 P labeling, and analyzed using purified 32 P-labeled yeast tRNA Phe as the size control. The pattern was identical to that seen with Mili as indicated in Fig. 4A (data not presented). The 32 P-labeled RNAs were subjected to tRNA microarray according to methods described previously (23) . Microarray data are displayed in the heat blot in Fig. 4B . Progressively redder and greener squares indicate greater and lesser abundance of specific tRNA species. The results are quantified further in the bar graph in Fig. 4C . Of note, two rare tRNAs were overrepresented on Mili. They were tRNA Ile (UAU) and tRNA Arg (UCU) ( Fig. 4B and C). They are indicated by red bars (Fig. 4C ). We conclude that Mili proteins bind to tRNA in cells and that some rare tRNAs bind better than expected.
Depletion of tRNA Arg (UCU) via an antisense oligonucleotide inhibits HIV replication. Both tRNA Ile (UAU) and tRNA Arg (UCU) were overrepresented on Mili ( Fig. 4B and C). To examine their effects on HIV replication, we chose tRNA Arg (UCU). Compared to tRNA Ile (UAU), which represents 14% of all tRNA Ile (23), tRNA Arg (UCU) represents only 5% of all tRNAs Arg . The more abundant ones include tRNA Arg (CCG), tRNA Arg (CCU), and tRNA Arg (ICG) in 293T cells ( Fig. 5A) (23) . Nevertheless, tRNA Arg (UCU) is encoded by 5 loci on different human chromosomes ( Fig. 5B ). Of interest, HIV NL4-3 contains 122 of these rare Arg-AGA codons, many of them in critical double-stranded regions, e.g., the RNA frame-shifting site (FS) between gag and pol and the Rev response element (RRE) ( Fig. 5C ).
Since tRNA Arg (UCU) is encoded on 5 different chromosomes, we could not inactivate all these genes using clustered regularly interspaced short palindromic repeat (CRISPR)/ Cas9 or related technologies. Rather, we synthesized an antisense (AS) oligonucleotide corresponding to tRNA Arg (UCU) sequence [Arg(UCU)]. An irrelevant (scrambled) oligonucleotide served as the negative control (C). As presented in Fig. 5D , when Arg(UCU) AS oligonucleotide was expressed in 293T cells, HIV replication was reduced 3-fold (upper panel, lanes 1 and 2). This finding was validated in activated CD4 ϩ T cells ( Fig. 5E, upper panel, lanes 1 and 2) . At the same time, we determined that the Arg(UCU) AS oligonucleotide depleted tRNA Arg (UCU) equivalently in these cells ( Fig. 5D and E, middle panels, lanes 1 and 2). Moreover, these AS oligonucleotides had no obvious effect on the viability of these cells ( Fig. 5D and E, lower panels, lanes 1 and 2). 4) . mw, molecular weight. (B) Mili binds preferentially to some tRNAs in cells. UV-irradiated (cross-linked) and anti-Piwil 2 immunoprecipitated RNA was subjected to 3= end labeling with 32 P, separated by the use of 10% TBE-urea gels, and submitted to autoradiography. The band corresponding to tRNA was cut out of the gel, eluted, and hybridized to a human tRNA microarray. A heat map of this microarray is presented. Relative abundances of these tRNA species on Mili are compared to those in cells. Increasing intensities of red and green signify greater and lesser abundances of these species, respectively. (C) Data corresponding to up-or downregulated tRNAs from the experiment described in the panel B legend are presented in this bar graph, with arrows highlighting rare tRNAs. Note that the rare tRNA Ile (UAU) and tRNA Arg (UCU) are overrepresented on Mili and are highlighted as red bars. Fold increased and decreased abundance values are given below the bar graph. We conclude that the depletion of tRNA Arg (UCU) has the same effect as that of Hili and that both decrease the translation as well as replication of HIV.
Hili also inhibits the replication of the intracysternal A particles (IAP) in cells.
Since Piwil proteins block the replication of endogenous mobile genetic elements during germ line development in the mouse, we also wanted to determine if Hili could function similarly in somatic cells. To this end, we employed a well-characterized, fully active IAP-marked retrotransposon (pFL). Of note, IAP contains many Arg-AGA codons: 18 in gag, 2 in protease and reverse transcriptase (PR), and 16 in pol, representing up to 40% of all Arg codons in the viral genome. Since Hili and Mili share 88% sequence identity and 93% sequence similarity, we also examined effects of Hili on pFL in human cells. pFL is diagrammed in Fig. 6A . An interrupted EGFP reporter gene was placed into its genome in the opposite orientation. Importantly, pFL-expressing cells turn green only after the complete round of retrotransposition, after the splicing of the introduced intron in the EGFP gene in the IAP sense orientation and transcription of the mature EGFP gene in the IAP antisense orientation from the introduced eukaryotic initiation factor 1 alpha (eIF1␣) promoter. The number of green cells then reflects the efficiency of retrotransposition ( Fig. 6A; fluorescent image) . Importantly, we performed our studies in cells that do not contain piRNAs (Fig. 4A ). After coexpressing transiently pFL and Hili in 293T cells for 72 h and counting over a thousand cells in three independent experiments, 10-fold-lower numbers of GFPexpressing cells were found in the presence of Hili than in its absence (Fig. 6B, bars 1 and 2). Expression of Hili is presented in Fig. 6C (top panel) . Similarly to the situation with HIV, when IAP-specific proteins (p73, Gag, p35, matrix [MA] and p24, CA) were examined, more than 5-fold-lower expression of Gag proteins was observed in the presence of Hili (Fig. 6C, middle panel, lanes 1 and 2) . Levels of actin served as the loading control (Fig. 6C, bottom panel, lanes 1 and 2) . These differences in protein expression levels occurred despite similar levels of gag transcripts of Hili-expressing and parental 293T cells transfected with an empty vector (Fig. 6D, lanes 1 and 2) , which were quantified using gag-specific primers and RT-qPCR. Finally, reverse transcription was compromised greatly in Hili-expressing cells (Fig. 6E, lanes 2 and 3) . These data indicate that despite identical levels of IAP transcripts, expression of IAP proteins is reduced greatly in Hili-expressing cells. We conclude that even in the absence of piRNAs, Piwil proteins restrict the movement of mobile genetic elements in cells. Thus, their increased expression in activated T cells could help safeguard the genome in these cells.
DISCUSSION
In this study, we discovered that Hili can inhibit HIV replication, especially in the activated CD4 ϩ T cells that are the preferred target cells for this virus in the infected host. Although resting cells do not express Hili, expression is rapidly induced following T cell activation. Other transformed cell lines express Hili constitutively. In them, depletion of Hili increased levels of viral proteins and new viral particles. Further studies revealed that in the absence of piRNAs, Hili binds to tRNA in these cells. Some of them represent rare tRNA species, whose codons are overrepresented in the viral genome. Targeting tRNA Arg (UCU) with an antisense oligonucleotide replicated effects of Hili and also inhibited HIV replication in transformed 293T as well as activated primary CD4 ϩ T cells. Importantly, Hili also inhibited the retrotransposition of IAP, an active endogenous retrovirus from the mouse, which also contains many Arg-AGA codons. Again, this occurred via the depletion of tRNAs rather than the formation and use of piRNAs. Thus, Hili joins a long list of host proteins that complicate the intricate intracellular trafficking of this human retrovirus.
We found that inducing Hili and depleting one of its target rare tRNAs had similar effects on HIV replication. Possibly, AS oligonucleotides targeting both tRNA Arg (UCU) and tRNA Ile (UAU) would have inhibited even more the replication of HIV. However, they should have greater deleterious side effects on host cells as well. In this report, we concentrated on Hili because its expression was induced following T cell activation. Nevertheless, other human Piwil proteins such as Hiwi, Piwil 3, and Hiwi 2, when expressed exogenously in cells, also inhibited HIV replication (data not presented). They contain similar PAZ and PIWI domains. Various levels of expression of Hili could also contribute to the elite controller phenotype of some HIV-infected individuals, as has been suggested for Schlafen 11 (24) . However, although Schlafen 11 also depletes tRNAs in cells, its expression is induced by interferon and not by T cell activation (2) . Thus, we did not coexpress and/or study cooperative effects of Hili and Schlafen 11 in our cells.
HIV is a very compact retrovirus, whose different transcripts must fold into the complicated RNA secondary structures that are required for its optimal replication. The choice of tRNA codons is thus mandated by the species where the virus originated, frequent cytosine deamination during reverse transcription by APOBEC3 proteins, and the demands of these secondary structures. For example, HIV full-length or genomic RNA contains the trans-activation region (TAR), packaging, Lys 3 tRNA priming, frameshifting, and RRE sequences and structures. They are required for transcription, nuclear export, translation, and packaging of RNA into new viral particles. HIV RNA structures that were even more complex were revealed by SHAPE analyses (25) . To this end, it is not surprising that HIV NL4-3 contains 122 rare Arg AGA codons, 5 and 7 of which are found in the frame-shifting site, which is required for the translation of the Gag-Pol polyprotein precursor protein, and in the RRE, respectively. Thus, the virus would have a difficult time substituting these rare codons for more abundant ones. HIV transcripts also overwhelm the infected cell. It has been estimated that the virus usurps up to 20% of the translational machinery in activated CD4 ϩ T cells (26) . Thus, viral transcripts would be more sensitive to the relative abundance of rare tRNA species than host transcripts. Small perturbations in the levels of these rare tRNAs would thus be expected to have greater effects on HIV than on host cell proteins.
tRNAs were observed in all studies of Piwil proteins. Indeed, tRNA degration products predominate with tetrahymena Piwil proteins (17, 18) . In another study, human Piwil proteins (Hiwi 2) also associated with tRNAs in somatic cells (19) . Indeed, Hiwi 2 bound preferentially to 9 specific tRNAs in a breast cancer cell line (19) . Although most tRNAs in those tumor cells were degraded or processed tRNA fragments, we found intact tRNAs in our study. Selected tRNAs are double stranded at their 5= and 3= ends. The distances between them are not sufficient to fit into the two separated RNA-binding pockets of the recently crystalized Piwil protein from silkworm (27) . Nevertheless, Hili could potentially unwind the secondary structure of selected tRNAs to separate their 5= and 3= ends. Alternatively, Hili could bind these tRNAs simply due to strong electrostatic interactions that would favor some but not other tRNAs. Importantly, these tRNAs do not contain optimal 5= U residues and 2=-O-methyl ribose modifications at appropriate positions (17, 19, 28, 29) . Thus, further structural studies will be required to determine how some tRNAs bind selectively to Hili.
Although piRNAs are critical for restricting the movement of mobile genetic elements in the germ line, depleting rare tRNA species could also play a significant role. Most endogenous mobile genetic elements originated from different species and contain rare codons. If they are not translated, they also do not jump and replicate. Thus, depleting rare tRNAs would have effects similar to those seen with piRNAs with these mobile genetic elements. To this end, it is of interest that Hili also restricted the movement of IAP, which is an intact mouse endogenous retrovirus, in our cells. This finding not only informs studies of Piwil proteins in organisms where piRNAs are not found but also adds another level of regulation to these restriction factors. Thus, transcriptional and translational effects of Piwil proteins could synergize for moreefficient protection of the genome from these mobile genetic elements in the germ line. Furthermore, their expression following cell activation could also protect the genome of rapidly dividing cells from such inadvertent expression and movement of endogenous retrotransposons and retroviruses.
Finally, manipulating the balance of rare tRNAs might represent an attractive antiviral strategy (30) . Should lower levels of these rare tRNAs be sufficient for host cell homeostasis but not support optimal viral replication, one could envision engineering a slower progression of disease, leading to more-robust antiviral immune responses. This could result in the creation of new elite controllers, who would be able to go for long periods of time without aggressive antiretroviral therapies. Possibly, introducing AS oligonucleotides or genetically inactivating some but not all of these tRNAs would achieve these goals.
MATERIALS AND METHODS
Cell culture, plasmids, antibodies, and siRNA. Human embryonic kidney 293 cells transformed with large T antigen (293T) and HeLa cells were maintained at 37°C with 5% CO 2 in Dulbecco's modification of Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS) and 100 mM L-glutamine. Jurkat cells were maintained at 37°C with 5% CO 2 in RPMI medium 1640 containing 10% FBS and 100 mM L-glutamine. 293T cells stably expressing mouse mili.EGFP fusion protein were a kind gift from Dubravka Pezic and Alexei Aravin (California Institute of Technology). Trima residuals from healthy donors (from the Trima aphoresis collection and enriched for PBMCs) were obtained from Blood Center of the Pacific (San Francisco, CA). PBMCs were then plated at 5 ϫ 10 6 cells/ml in 24-well plates, using RPMI 10% human serum Ab. After 30 min, nonadherent cells (peripheral blood lymphocytes [PBLs]) were isolated and cultured in complete RPMI medium (containing 10% FBS, 100 mM L-glutamine, and 100 g/ml streptomycin) with 30 units/ml interleukin-2 (IL-2) (Roche Applied Science). After isolation, PBLs (10 7 ) were activated with 5 g/ml PHA and 30 units/ml IL-2 for 2 days. CD4 ϩ T cells were selected from bulk PBMCs using negative bead selection (Dynal CD4 ϩ untouched beads; Invitrogen). CD4 ϩ T cells were maintained for 24 h in RPMI 1640 medium-10% FBS-30 units/ml IL-2 at 37°C with 5% CO 2 before activation and expansion using anti-CD3/anti-CD28 Dynabeads (Invitrogen).
The human hili gene was cloned downstream of oligonucleotides corresponding to the FLAG epitope-tagged peptide or upstream of a red fluorescent protein (RFP) gene into pcDNA 3.1 plasmid vector. pNL-GFP RRE splice acceptor [RRE(SA)] and pNL4-3-ΔE-EGFP were kind gifts from Manqing Li and Michael David (University of California, San Diego [UCSD]). Ago2-EGFP plasmid was obtained from Addgene. Reporter pNL4-3.luciferase (Luc) plasmid was obtained from the NIH AIDS Reagent Program. pFL was obtained from Kyoji Horie and has been described previously (31) . Anti-Piwil 2 antibody (H00055124-B03P) was purchased from Abnova. Anti-GFP antibody (A11122) and antitubulin were purchased from Life Technologies. Anti-HIV Gag p24 (MAB7360) and anti-HIV Gag p55 (RK-65-014) were purchased from R&D Systems and MBL International Corporation, respectively. Anti-IAP Gag antibodies were a kind gift from Bryan Cullen (32) . Small interfering RNA (siRNA) against Hili (4390771) and control siRNA (AM4635) were purchased from Ambion.
Luciferase and fluorescence assays. 293T cells growing in log phase were transfected with reporter pNL4-3.Luc plasmids with X-tremeGENE HP DNA transfection reagent (Roche). Luciferase activity in the cell lysate was determined 24 h later using a luciferase assay system (Promega) according to the manufacturer's instructions. Data were normalized with the protein concentrations of the cell lysates. Fluorescence microscopic analyses on pFL-expressing cells were performed as described previously (33) . Viral infectivity assays. 293T cells or 293T cells stably expressing mili.EGFP (293T.mili) were transfected with the reporter pNL4-3.Luc plasmids (1 g) and empty vector (C) (1 g) or the plasmid encoding FLAG.hili (1 g) with 6 l X-tremeGENE HP DMA transfection reagent. At 24 h after transfection, the culture supernatants were collected. The amounts of HIV particles produced from the cells were determined by Gag p24 ELISA (Cell Technologies). The same volumes of culture supernatants were added to TZM-bl cells containing Tat-driven luciferase reporter gene and CD4, and luciferase activities were measured 24 h after the addition of supernatants to determine the amount of infectious viruses. Relative levels of infectivity of HIV produced from cells with or without ectopic expression of Hili or Mili were determined by calculating the ratio between the luciferase activity and total viral production.
RNA-IP. 293T.mili cells were UV irradiated (400 J/m 2 ) to cross-link protein and RNAs. Cells were lysed in radioimmunoprecipitation assay (RIPA) buffer (25 mM Tris-HCl [pH 7.6], 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) containing protease and RNase inhibitors. Cell lysates were incubated with anti-Piwil 2, anti-GFP, or normal rabbit IgG precoupled with protein A-conjugated Dynabeads (Life Technologies). After extensive washing of the beads with RIPA buffer, RNAs bound to the beads were isolated by incubation with 20 g proteinase K (New England Biolabs) in the presence of RNase inhibitors for 1 h at 55°C followed by phenol-chloroform extraction and ethanol precipitation. The purified RNAs were separated in a 15% TBE-urea gel and visualized with Sybr gold reagent (Life Technologies). Yeast tRNA and an RNA ladder (Biooscientific) were used as size markers.
Quantitative reverse transcriptase PCR (RT-qPCR) analysis. Total RNA was extracted using TRIzol reagent (Invitrogen), treated with Turbo DNase (Ambion), and subjected to reverse transcription using a SuperScript III First Strand system (Invitrogen) and random hexamers to produce cDNA. Real-time PCR was performed using a Stratagene Mx3004P real-time PCR system and SensiFAST Sybr green reagents (Bioline) following the manufacturer's protocol. Results were normalized to the levels of GAPDH (glyceraldehyde-3-phosphate dehydrogenase). Control reaction mixtures lacking reverse transcriptase (RT-minus) were routinely incorporated and indicated at least 10-fold-lower signal in all experiments. The primer sequences used in this study were as follows: hili primers, forward, 5=-TTGTCTGCTAATCTGG TACGC-3=, reverse, 5=-CATCTGAACTCCCTCTTCCAAG-3=; GFP primers, forward, 5=-CTGGAGTTGTCCCAATT CTTG-3=, reverse, 5=-TCACCCTCTCCACTGACAGA-3=; EGFP primers, forward, 5=-CAGCAGAACACCCCCATC-3=, reverse, 5=-TGGGTGCTCAGGTAGTGGTT-3=; GAPDH primers, forward, 5=-CCTGTCCTGTGTGCTGTAAT-3=, reverse, 5=-GAGAATGTGTATTGGCCTGGA-3=; and IAP-gag primers, F, 5=-ACC CAG GAA GCA GTC AGA GA-3=; R, 5=-CCT TTA GGG CTT GAG CAC AG-3=.
Genetic inactivation of Hili. For siRNA knockdown, 293T, HeLa, or Jurkat cells were transfected with siRNA aganst Hili or with control siRNA (40 nM) using Lipofectamine RNAiMax (Invitrogen). At 24 h after tranfection, the reporter pNL4-3 Luc plasmid was transfected with X-tremeGENE HP DNA transfection reagent. At 24 h after transfection of the reporter plasmid, culture supernatants were collected and viral production was quantified by Gag p24 ELISA. RNA or protein expression of Hili was measured by RT-qPCR or Western blot analysis, respectively.
UV cross-linking immunoprecipitation followed by tRNA microarray (Clip-chip). The tRNA species that interacted specifically with Hili were determined by Clip-chip experiments as previously described (22) . 293T.mili cells were UV irradiated (400 mJ/cm 2 at 254 nm). Anti-Piwil 2 antibodies were used to immunoprecipitate associated RNA species. RNA species were subjected to tRNA microarray analysis as described before (34) (35) (36) . Briefly, immunoprecipitated RNAs were released from protein A beads and the RNAs were recovered by ethanol precipitation. The RNA was subjected to 3=-end 32 P labeling using [5=-32 P]pCp and T4 RNA ligase. The 32 P-labeled mixture was directly analyzed using 10% denaturing PAGE and purified 32 P-labeled yeast tRNA Phe as a size control. To analyze the 32 P-labeled RNA by tRNA microarray, the corresponding tRNA-sized bands were cut out of the gel and eluted with crush and soak buffer (50 mM KOAc-200 mM KCl, pH 7.0) at 4°C overnight. The eluted RNA was recovered by ethanol precipitation and dissolved in water. tRNA microarray preparation, hybridization, and data analyses were performed according to methods described previously (22, 34) .
tRNA sequencing and analysis. Total RNA was extracted from 293T cells and was used to construct a transcriptome library using a NEBNext Small RNA Library Prep Set for Illumina (Multiplex Compatible) (catalog no. E7330S; New England Biolabs). The constructed library was analyzed for small RNA using a HiSeq 2000 next-generation platform at BGI-Tech. The (paired-end) sequencing read length of the library was 100 bp. Raw FASTQ reads were mapped to human reference genome with tophat (v2.0.10). The parameters were set as following: tophat -p 16 - Antisense tRNA assays. 293T cells were grown in 24-well culture plates for 24 h prior to transfection. Cells were then transfected with the reporter pNL4-3.Luc plasmid (0.5 g) and 4 g of antisense oligonucleotide DNA corresponding to the anti-codon region of tRNA Arg (UCU) (TAGAAGTCCAATGCGCT ATCCATTGCG) or a randomized negative control (AGTCTTATGCTTGCCCAGCAGGCTAAA). At 24 h after transfection, virus production in culture supernatants was quantified by Gag p24 ELISA, and luciferase activity in cell lysates were measured as described previously (37) . Gag p24 levels were normalized to luciferase activities. Relative levels of targeted tRNA were measured after antisense transfection by
